logo

MSTR

Strategy·NASDAQ
--
--(--)
--
--(--)
4.35 / 10
Netural

Fundamental assessment scores 4.3/10, indicating fair health. Strengths include net‑income‑to‑revenue ratio, long‑term debt‑to‑working‑capital, and favorable PB‑ROE, Asset‑MV and Profit‑MV metrics. Weak points are declining cash‑UP, high inventory turnover days, and limited cash reserves, warranting guarded consideration.

Fundamental(4.35)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-3.26
Score2/3
Weight6.81%
1M Return5.60%
Asset-liability ratio (%)
Value17.19
Score3/3
Weight4.51%
1M Return3.11%
Profit-MV
Value0.66
Score2/3
Weight2.36%
1M Return2.00%
Net income-Revenue
Value-0.04
Score3/3
Weight6.14%
1M Return4.69%
PB-ROE
Value-0.42
Score2/3
Weight7.96%
1M Return6.86%
Cash-UP
Value-0.15
Score1/3
Weight-6.72%
1M Return-8.11%
Long-term debt to working capital ratio (%)
Value4.81
Score3/3
Weight9.04%
1M Return6.27%
Asset-MV
Value-0.55
Score2/3
Weight64.00%
1M Return25.82%
Inventory turnover days
Value212.62
Score1/3
Weight-0.24%
1M Return-0.17%
Cash-MV
Value0.02
Score3/3
Weight6.12%
1M Return5.26%
Is MSTR undervalued or overvalued?
  • MSTR scores 4.35/10 on fundamentals and holds a Fair valuation at present. Backed by its -12.21% ROE, -806.35% net margin, -11.37 P/E ratio, 0.94 P/B ratio, and -151.32% earnings growth, these metrics solidify its Netural investment rating.